For the Inventor, By the Inventor

Enter assignee name

National Institutes of Biomedical Innovation, Health and Nutrition

USPTO Granted Patents = 21

CIPO Patents = 1

EPO Patents = 9

Trademarks = 1

Forward Citations = 13

Loading Chart...

Loading Chart...

67 inventors (with patents filed for the assignee):

Ken Ishii (5 out of 43 patents)

Satoshi Obika (4 out of 30 patents)

Yuya Kasahara (4 out of 6 patents)

4. Taiki Aoshi (3 out of 3 patents)

5. Tetsuji Naka (3 out of 6 patents)

6. Satoshi Serada (3 out of 6 patents)

7. Ayako Kakiuchi (2 out of 2 patents)

8. Shuji Hayashi (2 out of 2 patents)

9. Izumi Yanagisawa (2 out of 2 patents)

10. Atsuhiko Kato (2 out of 13 patents)

11. Ryo Konno (2 out of 4 patents)

12. Sachiho Netsu (2 out of 2 patents)

13. Tadashi Sankai (2 out of 2 patents)

14. Tomonori Kimura (2 out of 32 patents)

15. Yuji Kasuya (2 out of 23 patents)

21 patents: Sort by Forward Citations

1. 12480954 - Method for assisting evaluation of condition of kidneys, system for evaluating condition of kidneys, and program for evaluating condition of kidneys (2025-11-25),

2. 12360117 - Method for determining glomerular filtration ability (2025-07-15),

3. 12331092 - Leucine-rich ALPHA2 glycoprotein composition (2025-06-17),

4. 12306171 - Method for detecting indicator of immune-related disease (2025-05-20),

5. 12281158 - Prophylactic and/or therapeutic agent of infectious diseases or inflammatory diseases (2025-04-21),

6. 12222351 - Immunoassay and measurement reagent for leucine-rich alpha2 glycoprotein (2025-02-11),

7. 12071624 - Antisense oligonucleotide targeting ARL4C molecule, and nucleic acid drug using antisense oligonucleotide (2024-08-27),

8. 11866705 - Small cell lung cancer therapeutic agent containing oligonucleotide (2024-01-09),

9. 11780912 - Composition for prophylaxis or treatment of IL-8 related diseases (2023-10-10),

10. 11479773 - Antisense nucleic acid for inhibiting biosynthesis of chondroitin sulfate (2022-10-25),

11. 11442066 - Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein (2022-09-13),

12. 11268098 - Non-aggregating immunostimulatory oligonucleotides (2022-03-08),

13. 11234995 - α-synuclein expression inhibitor (2022-02-01),

14. 11222423 - Evaluation device, observation device, and program for identifying cell differentiation (2022-01-11),

15. 11058758 - TH1-inducing adjuvant comprising combination of different nucleic acid adjuvants, and use of same (2021-07-13),

The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) is a research organization that focuses on promoting innovations in the field of health and nutrition. NIBIOHN conducts cutting-edge research, collaborates with international partners, and fosters the development of new technologies and treatments. Their mission is to contribute to the well-being of society by advancing scientific knowledge and improving the health and quality of life of individuals.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

21 Patents

#14 in Ibaraki

#2,800 in Japan

#29,078 in the World

National Institutes of Biomedical Innovation, Health and Nutrition

Forward Citations = 13

67 inventors:

Ken Ishii (5 out of 43 patents)

Satoshi Obika (4 out of 30 patents)

Yuya Kasahara (4 out of 6 patents)

4. Taiki Aoshi (3 out of 3 patents)

5. Tetsuji Naka (3 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…